ReviewJournal of pain research2023

A Review of the Therapeutic Targeting of SCN9A and Nav1.7 for Pain Relief in Current Human Clinical Trials.

Anton Dormer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.